Back
Trevi Therapeutics Stock Price Chart
Sponsored
TRVI
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
49
TRVI
Trevi Therapeutics
Last Price:
$3.99
Seasonality Move:
52.76%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and TRVI is experiencing selling pressure, which indicates risk of future bearish movement.
Trevi Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.17 | Sell |
20-day SMA: | 3.35 | Buy |
50-day SMA: | 3.15 | Buy |
200-day SMA: | 2.98 | Buy |
8-day EMA: | 3.95 | Buy |
20-day EMA: | 3.56 | Buy |
50-day EMA: | 3.26 | Buy |
200-day EMA: | 2.91 | Buy |
Trevi Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 63.29 | Buy |
Chaikin Money Flow: | -255608 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.59 - 3.91) | Buy |
Bollinger Bands (100): | (2.7 - 3.48) | Buy |
Trevi Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 4.00 while TRVI 8-day simple moving average is 4.17, which is a Sell signal.
-
The stock price of TRVI is 4.00 while Trevi Therapeutics 20-day SMA is 3.35, which makes it a Buy.
-
Trevi Therapeutics 50-day simple moving average is 3.15 while TRVI share price is 4.00, making it a Buy technically.
-
TRVI stock price is 4.00 and Trevi Therapeutics 200-day simple moving average is 2.98, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Sell
49
Trevi Therapeutics (TRVI)
is a Sell
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a SellThe current Trevi Therapeutics [TRVI] share price is $4.00. The Score for TRVI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
307.5M
Price in USD:
4.00
Share Volume:
441.5K
Trevi Therapeutics 52-Week Range
52-Week High:
4.68
52-Week Low:
1.27
Sell
49
Trevi Therapeutics (TRVI)
is a Sell
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 4.00 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 4.00 while TRVI 8-day exponential moving average is 3.95, which is a Buy signal.
-
The stock price of TRVI is 4.00 while Trevi Therapeutics 20-day EMA is 3.56, which makes it a Buy.
-
Trevi Therapeutics 50-day exponential moving average is 3.26 while TRVI share price is 4.00, making it a Buy technically.
-
TRVI stock price is 4.00 and Trevi Therapeutics 200-day simple moving average is 2.91, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.00 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.33, suggesting Trevi Therapeutics is a Buy
-
Trevi Therapeutics Relative Strength Index (RSI) is 63.29, which suggest Trevi Therapeutics is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics is (2.59 - 3.91), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (2.7 - 3.48), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.